HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

Estee Lauder Aims To Trump The Competition With New Men’s Scent

This article was originally published in The Rose Sheet

  • News
  • The Rose Sheet

Executive Summary

Estee Lauder's Aramis and Designer Fragrances division will support the launch of its newest men's scent, Donald Trump, The Fragrance,with a print advertising campaign featuring the real estate tycoon turned TV star, the company announced

You may also be interested in...



Lauder Partners With True Star Iglesias To Launch Men’s Fragrance

Estee Lauder has tapped singer Enrique Iglesias as the spokesman for the Tommy Hilfiger True Star Men fragrance. The multi-year deal was announced Feb. 1

Lauder Partners With True Star Iglesias To Launch Men’s Fragrance

Estee Lauder has tapped singer Enrique Iglesias as the spokesman for the Tommy Hilfiger True Star Men fragrance. The multi-year deal was announced Feb. 1

Sean John Fragrances Will Debut Under Lauder License

Estee Lauder is aiming to launch a line of Sean John fragrances in fall 2005, the firm said. The company announced it had signed a licensing agreement with Sean John founder Sean "P. Diddy" Combs May 21

Table

View full table

Tags:
Latest Headlines

Cosmetic And Personal Care Trademark Review: 16 April

Health And Wellness Weekly Trademarks Review: 16 April

Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States

Prestige Expands UK Eye Care Range In Response To Consumer Demand

See All
UsernamePublicRestriction

Register

RS012475

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By